Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFOPAM vs NEMOLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFOPAM vs NEMOLIZUMAB: Safety Overview

Metric NEFOPAM NEMOLIZUMAB
Total FAERS Reports 2,857 371
Deaths Reported 360 54
Death Rate 12.6% 14.6%
Hospitalizations 1,685 136
Average Patient Age 55.0 yrs 63.9 yrs
% Female Patients 54.4% 37.5%
Manufacturer N/A Galderma Laboratories, L.P.
Route N/A SUBCUTANEOUS